Effect of Wearable Devices on Patient-Reported Outcomes and Clinical Utilization: A Randomized, Controlled Trial


About this study

The purpose of this study is to help researchers better understand the impact of wearable devices on patient experience and clinical trends following a cardioversion.



Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 22 years old.
  • English-speaking.
  • Planned for outpatient direct current cardioversion for atrial fibrillation or atrial flutter.
  • Participant is willing and able to read and sign consent and participate in study.
  • Participant lives independently and does not require continuous care.
  • Participant has an email account (or is willing to create one).
  • Participant has a compatible smartphone (iPhone 6s or later).
  • Participant is willing to wear only the device they are randomized to receive for the study period for as many hours during the day as they are able, except for the time spent charging the device or in the environments that may be suboptimal for the device.
  • Participant is willing to use the Hugo mobile health platform and Apple Watch Series 5 or Withings Move.
  • Participant has cardiology care at Mayo Clinic and primary care in a health system with a patient portal.

Exclusion Criteria:

  • Do not meet all inclusion criteria as listed above
  • Unable to provide informed consent.

Eligibility last updated 1/24/22. Questions regarding updates should be directed to the study team contact.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Peter Noseworthy, M.D.

Closed-enrolling by invitation

What is this? (?)
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Lindsay Emanuel

(507) 422-6300


More information


Publications are currently not available

Mayo Clinic Footer